Evgen Pharma PLC (AIM:EVG), the clinical-stage drug development company, has announced the termination of its patent and know-how licence agreement with.
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
AIM - WINNERS
Blancco Technology Group PLC, up 23% at 219.56 pence, 12-month range.
Evgen Pharma PLC - Cheshire, England-based clinical stage drug development company focused on developing sulforaphane-based medicines - Terminates the patent and know-how license agreement for its.